Prevention of glucocorticoid-induced osteoporosis

By van Brussel MS   Bultink IEM   Lems WF  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Pathogenesis and Treatment of Glucocorticoid-Induced Osteoporosis

By Rackoff P.J.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 477-484

Adis International

Access to resources Recommend Favorite

The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice

By Walker-Bone Karen   Wood Angela   Hull Richard   Ledingham Joanna M   McCrae Fiona C   Shaban Ragai   Thomas Alastair   Mackay Kirsten  

Clinical Medicine, Vol. 4, Iss. 5, 2004-09 ,pp. : 431-436

Royal College Of Physicians

Access to resources Recommend Favorite

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

By Bultink Irene EM   Baden Marijke   Lems Willem F  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 185-197

Informa Healthcare

Access to resources Recommend Favorite

Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate

By Djalali Mahmoud  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 5, 2013-01 ,pp. : 380-385

NRC Research Press

Access to resources Recommend Favorite